[
2-[18F]fluoroethylazide
Lutathera
clinical translation
fluorine-18
octreotide
positron emission tomography
radiopharmaceuticals
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
02 Apr 2020
02 Apr 2020
Historique:
received:
09
03
2020
revised:
26
03
2020
accepted:
31
03
2020
entrez:
8
4
2020
pubmed:
8
4
2020
medline:
8
4
2020
Statut:
epublish
Résumé
The success of Lutathera™ ([
Identifiants
pubmed: 32252406
pii: cancers12040865
doi: 10.3390/cancers12040865
pmc: PMC7226534
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : Medical Research Council
ID : MR/J007986/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N020782/1
Pays : United Kingdom
Références
J Nucl Med. 2013 Jun;54(6):855-60
pubmed: 23516312
Onco Targets Ther. 2017 Oct 03;10:4821-4828
pubmed: 29042793
Eur J Nucl Med Mol Imaging. 2003 Jan;30(1):117-22
pubmed: 12483418
Sci Rep. 2019 Dec 17;9(1):19299
pubmed: 31848442
J Nucl Med. 2010 Mar;51(3):454-61
pubmed: 20150268
Bioconjug Chem. 2015 Dec 16;26(12):2350-9
pubmed: 26420336
J Nucl Med. 2018 Jan;59(1):66-74
pubmed: 29025982
EJNMMI Radiopharm Chem. 2020 Jan 29;5(1):4
pubmed: 31997090
Nucl Med Biol. 2012 Oct;39(7):1000-5
pubmed: 22575271
Bioconjug Chem. 2005 Nov-Dec;16(6):1572-9
pubmed: 16287257
J Nucl Med. 2015 Jul;56(7):1100-5
pubmed: 25977461
Bioconjug Chem. 2002 Jul-Aug;13(4):721-8
pubmed: 12121126
Theranostics. 2019 Feb 14;9(5):1336-1347
pubmed: 30867834
Clin Cancer Res. 2004 Jun 1;10(11):3593-606
pubmed: 15173065
J Nucl Med. 2016 Aug;57(8):1207-13
pubmed: 27173162
J Nucl Med. 2006 Apr;47(4):566-73
pubmed: 16595488
Molecules. 2015 Jul 16;20(7):12913-43
pubmed: 26193247
Eur J Nucl Med Mol Imaging. 2020 Apr;47(4):870-880
pubmed: 31492994
Pharmaceuticals (Basel). 2019 Jul 29;12(3):
pubmed: 31362406
Bioconjug Chem. 2007 May-Jun;18(3):989-93
pubmed: 17429938
Drug Discov Today. 2017 Oct;22(10):1572-1581
pubmed: 28676407
Eur J Nucl Med Mol Imaging. 2008 Jan;35(1):72-9
pubmed: 17874094
Appl Radiat Isot. 2013 Jun;76:2-13
pubmed: 23522791
Br J Radiol. 2018 Nov;91(1091):20180440
pubmed: 30179054
Cancer Biother Radiopharm. 2009 Aug;24(4):379-93
pubmed: 19694573
Nat Protoc. 2016 Jun;11(6):1057-66
pubmed: 27172166
J Nucl Med. 2011 Sep;52(9):1441-8
pubmed: 21852355
Bioorg Med Chem Lett. 2011 Dec 1;21(23):6945-9
pubmed: 22030029
Bioorg Med Chem Lett. 2011 May 15;21(10):3122-7
pubmed: 21458258
Semin Nucl Med. 2001 Oct;31(4):296-311
pubmed: 11710772
J Am Chem Soc. 2013 Jan 16;135(2):703-9
pubmed: 23194416
J Nucl Med. 2020 Jan 10;:
pubmed: 31924723
Org Biomol Chem. 2015 Oct 7;13(37):9528-50
pubmed: 26284434
N Engl J Med. 2017 Jan 12;376(2):125-135
pubmed: 28076709
Angew Chem Int Ed Engl. 2014 Oct 27;53(44):11876-80
pubmed: 25196467
Eur J Nucl Med Mol Imaging. 2008 Feb;35(2):264-71
pubmed: 17912524
J Nucl Med. 2017 Mar;58(3):451-457
pubmed: 27660147
Bioconjug Chem. 2017 Feb 15;28(2):583-589
pubmed: 28150941
Bioconjug Chem. 2016 Nov 16;27(11):2707-2714
pubmed: 27715017
J Nucl Med. 2014 Sep;55(9):1499-505
pubmed: 24970911
Eur J Nucl Med Mol Imaging. 2019 Oct;46(11):2398-2399
pubmed: 31367905
Nuklearmedizin. 2009;48(5):201-7
pubmed: 19639164
J Nucl Med. 2004 May;45(5):892-902
pubmed: 15136641
Appl Radiat Isot. 2018 Mar;133:1-3
pubmed: 29272820
Nucl Med Biol. 2012 Nov;39(8):1175-81
pubmed: 22770647
J Am Chem Soc. 2004 Aug 4;126(30):9152-3
pubmed: 15281783
J Nucl Med. 2012 Aug;53(8):1207-15
pubmed: 22782315
Eur J Nucl Med Mol Imaging. 2019 Oct;46(11):2225-2227
pubmed: 31392370
J Nucl Med. 2017 Sep;58(Suppl 2):61S-66S
pubmed: 28864614